Cargando…

Identification and characterization of myocardial metastases in neuroendocrine tumor patients using 68Ga-DOTATATE PET-CT

BACKGROUND: Focal 68Ga-DOTATATE PET lesions within the myocardium of neuroendocrine tumor (NET) patients are observed in clinical practice. We determined the frequency and characteristics of lesions that are consistent with cardiac metastasis and assessed the lesion detection rate of conventional im...

Descripción completa

Detalles Bibliográficos
Autores principales: Kunz, Wolfgang G., Eschbach, Ralf S., Stahl, Robert, Kazmierczak, Philipp M., Bartenstein, Peter, Rominger, Axel, Auernhammer, Christoph J., Spitzweg, Christine, Ricke, Jens, Cyran, Clemens C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6149059/
https://www.ncbi.nlm.nih.gov/pubmed/30236163
http://dx.doi.org/10.1186/s40644-018-0168-2
_version_ 1783356811807555584
author Kunz, Wolfgang G.
Eschbach, Ralf S.
Stahl, Robert
Kazmierczak, Philipp M.
Bartenstein, Peter
Rominger, Axel
Auernhammer, Christoph J.
Spitzweg, Christine
Ricke, Jens
Cyran, Clemens C.
author_facet Kunz, Wolfgang G.
Eschbach, Ralf S.
Stahl, Robert
Kazmierczak, Philipp M.
Bartenstein, Peter
Rominger, Axel
Auernhammer, Christoph J.
Spitzweg, Christine
Ricke, Jens
Cyran, Clemens C.
author_sort Kunz, Wolfgang G.
collection PubMed
description BACKGROUND: Focal 68Ga-DOTATATE PET lesions within the myocardium of neuroendocrine tumor (NET) patients are observed in clinical practice. We determined the frequency and characteristics of lesions that are consistent with cardiac metastasis and assessed the lesion detection rate of conventional imaging. METHODS: 629 patients who underwent 68Ga-DOTATATE PET-CT at a supraregional comprehensive cancer center on NET were included from a consecutive registry. Inclusion criteria were: (1) focal 68Ga-DOTATATE tracer uptake within the myocardium in more than two sequential PET exams, and (2) contrast-enhanced CT. To determine the diagnostic accuracy of conventional CT imaging, a case-control cohort with a ratio of 1:3 was used. PET and CT were independently analyzed by two blinded readers. Cohen’s κ was assessed for interreader agreement. Descriptive statistics were applied for frequencies and characteristics and group comparisons were analyzed using the Fisher’s exact test. RESULTS: The prevalence of myocardial metastases related to the registry was 2.4% (15 of 629 NET patients fulfilling the inclusion criteria), for a total of 21 myocardial 68Ga-DOTATATE foci detected. Myocardial lesions were most frequently located in the left ventricle (43%) and the septum (43%). No patient demonstrated a pericardial effusion. Patients with myocardial metastases did not differ in demographics, tumor grading, disease stage or circulating tumor markers compared to the overall registry (all p > 0.05). Higher Ki67-Indices were observed (p = 0.049) for patients with myocardial metastases. Interreader agreement for PET assessment was excellent (Cohen’s κ = 1.0). CT reading showed a sensitivity of 19% (95% confidence interval: 6–43%) at a specificity of 100% (95% confidence interval: 90–100%). CONCLUSIONS: 68Ga-DOTATATE PET enables detection of myocardial metastatic lesions in NET patients. In contrast, standard morphologic CT imaging provides very limited sensitivity.
format Online
Article
Text
id pubmed-6149059
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-61490592018-09-26 Identification and characterization of myocardial metastases in neuroendocrine tumor patients using 68Ga-DOTATATE PET-CT Kunz, Wolfgang G. Eschbach, Ralf S. Stahl, Robert Kazmierczak, Philipp M. Bartenstein, Peter Rominger, Axel Auernhammer, Christoph J. Spitzweg, Christine Ricke, Jens Cyran, Clemens C. Cancer Imaging Research Article BACKGROUND: Focal 68Ga-DOTATATE PET lesions within the myocardium of neuroendocrine tumor (NET) patients are observed in clinical practice. We determined the frequency and characteristics of lesions that are consistent with cardiac metastasis and assessed the lesion detection rate of conventional imaging. METHODS: 629 patients who underwent 68Ga-DOTATATE PET-CT at a supraregional comprehensive cancer center on NET were included from a consecutive registry. Inclusion criteria were: (1) focal 68Ga-DOTATATE tracer uptake within the myocardium in more than two sequential PET exams, and (2) contrast-enhanced CT. To determine the diagnostic accuracy of conventional CT imaging, a case-control cohort with a ratio of 1:3 was used. PET and CT were independently analyzed by two blinded readers. Cohen’s κ was assessed for interreader agreement. Descriptive statistics were applied for frequencies and characteristics and group comparisons were analyzed using the Fisher’s exact test. RESULTS: The prevalence of myocardial metastases related to the registry was 2.4% (15 of 629 NET patients fulfilling the inclusion criteria), for a total of 21 myocardial 68Ga-DOTATATE foci detected. Myocardial lesions were most frequently located in the left ventricle (43%) and the septum (43%). No patient demonstrated a pericardial effusion. Patients with myocardial metastases did not differ in demographics, tumor grading, disease stage or circulating tumor markers compared to the overall registry (all p > 0.05). Higher Ki67-Indices were observed (p = 0.049) for patients with myocardial metastases. Interreader agreement for PET assessment was excellent (Cohen’s κ = 1.0). CT reading showed a sensitivity of 19% (95% confidence interval: 6–43%) at a specificity of 100% (95% confidence interval: 90–100%). CONCLUSIONS: 68Ga-DOTATATE PET enables detection of myocardial metastatic lesions in NET patients. In contrast, standard morphologic CT imaging provides very limited sensitivity. BioMed Central 2018-09-20 /pmc/articles/PMC6149059/ /pubmed/30236163 http://dx.doi.org/10.1186/s40644-018-0168-2 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Kunz, Wolfgang G.
Eschbach, Ralf S.
Stahl, Robert
Kazmierczak, Philipp M.
Bartenstein, Peter
Rominger, Axel
Auernhammer, Christoph J.
Spitzweg, Christine
Ricke, Jens
Cyran, Clemens C.
Identification and characterization of myocardial metastases in neuroendocrine tumor patients using 68Ga-DOTATATE PET-CT
title Identification and characterization of myocardial metastases in neuroendocrine tumor patients using 68Ga-DOTATATE PET-CT
title_full Identification and characterization of myocardial metastases in neuroendocrine tumor patients using 68Ga-DOTATATE PET-CT
title_fullStr Identification and characterization of myocardial metastases in neuroendocrine tumor patients using 68Ga-DOTATATE PET-CT
title_full_unstemmed Identification and characterization of myocardial metastases in neuroendocrine tumor patients using 68Ga-DOTATATE PET-CT
title_short Identification and characterization of myocardial metastases in neuroendocrine tumor patients using 68Ga-DOTATATE PET-CT
title_sort identification and characterization of myocardial metastases in neuroendocrine tumor patients using 68ga-dotatate pet-ct
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6149059/
https://www.ncbi.nlm.nih.gov/pubmed/30236163
http://dx.doi.org/10.1186/s40644-018-0168-2
work_keys_str_mv AT kunzwolfgangg identificationandcharacterizationofmyocardialmetastasesinneuroendocrinetumorpatientsusing68gadotatatepetct
AT eschbachralfs identificationandcharacterizationofmyocardialmetastasesinneuroendocrinetumorpatientsusing68gadotatatepetct
AT stahlrobert identificationandcharacterizationofmyocardialmetastasesinneuroendocrinetumorpatientsusing68gadotatatepetct
AT kazmierczakphilippm identificationandcharacterizationofmyocardialmetastasesinneuroendocrinetumorpatientsusing68gadotatatepetct
AT bartensteinpeter identificationandcharacterizationofmyocardialmetastasesinneuroendocrinetumorpatientsusing68gadotatatepetct
AT romingeraxel identificationandcharacterizationofmyocardialmetastasesinneuroendocrinetumorpatientsusing68gadotatatepetct
AT auernhammerchristophj identificationandcharacterizationofmyocardialmetastasesinneuroendocrinetumorpatientsusing68gadotatatepetct
AT spitzwegchristine identificationandcharacterizationofmyocardialmetastasesinneuroendocrinetumorpatientsusing68gadotatatepetct
AT rickejens identificationandcharacterizationofmyocardialmetastasesinneuroendocrinetumorpatientsusing68gadotatatepetct
AT cyranclemensc identificationandcharacterizationofmyocardialmetastasesinneuroendocrinetumorpatientsusing68gadotatatepetct